| Financial Year |
March 31 2022 |
| Monetary Funds |
4,365,271.51 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
539,626.46 |
| Advances to Suppliers |
-- |
| Other Receivables |
593,895.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
282,216.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,324,535.81 |
| Total Current Assets |
9,105,545.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
6,842,278.86 |
| Fixed Assetes |
30,527,318.52 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,564,990.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,177,709.52 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
74,112,297.67 |
| Total Assets |
83,217,843.18 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
917,533.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,288,084.31 |
| Taxes Payable |
332,334.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,250,692.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
69,022.87 |
| Other Current Liabilities |
51,437.20 |
| Sub-Total of Current Liabilities |
7,766,391.75 |
| Long-term Loans |
3,230,217.54 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,489,685.04 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,719,902.58 |
| Total Liabilities |
12,486,294.33 |
| Paid-In Capital(Or Share Stock) |
364,100,000.00 |
| Capital Surplus |
58,856,994.26 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-352,225,445.41 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
70,731,548.85 |
| Owner's Equity（Stockholder's Equity） |
70,731,548.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
83,217,843.18 |
